EW vs HYPD · P/E 47, rev $1.39B vs rev $57.3K
Edwards Lifesciences Corp (EW) versus Hyperion DeFi, Inc. (HYPD) — a side-by-side from cached financials, not a winner call.
Edwards Lifesciences Corp (EW) is a medical devices company listed on NYSE.
Hyperion DeFi, Inc. (HYPD) is a biotechnology company listed on NASDAQ.
Latest reported EW revenue for 2024-12-31 was $1.39B. Net income was $385.6M. Revenue was up 2.3% from 2024-09-30 to 2024-12-31. EW currently screens at market cap $49.91B and trailing P/E 46.9.
Latest reported HYPD revenue for 2024-12-31 was $57.3K. Net income was -$49.8M. Revenue was up 1414.0% from 2023-12-31 to 2024-12-31. HYPD currently screens at market cap $48.5M.
EW currently screens at market cap $49.91B and trailing P/E 46.9. HYPD currently screens at market cap $48.5M.
Not investment advice. Open the EW and HYPD stock pages for the full models.
Not investment advice.